Thu, February 10, 2022
Wed, February 9, 2022
Tue, February 8, 2022

Jim Birchenough Maintained (ZYME) at Buy with Decreased Target to $48 on, Feb 9th, 2022

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-48-on-feb-9th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Jim Birchenough of Wells Fargo, Maintained "Zymeworks Inc." (ZYME) at Buy with Decreased Target from $56 to $48 on, Feb 9th, 2022.

Jim has made no other calls on ZYME in the last 4 months.



There are 2 other peers that have a rating on ZYME. Out of the 2 peers that are also analyzing ZYME, 0 agree with Jim's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jim


  • Andrew Berens of "SVB Leerink" Upgraded from Hold to Buy on, Friday, December 10th, 2021
  • David Novak of "Raymond James" Downgraded from Strong Buy to Buy and Held Target at $74 on, Friday, December 10th, 2021